低劑量免疫治療是否一樣有效？最新臨床試驗結果分享 Is Low-Dose Immunotherapy Just as Effective? Insights from Clinical Trials

腫瘤科吳教恩醫師
腫瘤科吳教恩醫師
3 觀看·2026年2月9日

這段影片將探討低劑量免疫治療的有效性，並分享最新臨床試驗的結果。免疫治療藥物如PD-1或PD-L1抑制劑常用於標準劑量治療癌症，但越來越多研究關注降低劑量是否能達到相同效果，同時減少副作用與成本。影片中將詳細解說目前的臨床試驗發現，幫助大家了解低劑量治療的潛力及其挑戰。

This video explores the effectiveness of low-dose immunotherapy and shares the latest findings from clinical trials. Immunotherapy drugs like PD-1 or PD-L1 inhibitors are commonly used at standard doses to treat cancer, but recent studies are focusing on whether reduced doses can achieve similar results while minimizing side effects and costs. In this video, we’ll dive into the latest trial data and discuss the potential and challenges of low-dose treatment.